Secondary amyloidosis has decreased in patients with inflammatory joint disease in Finland

Clinical Rheumatology

Volumn 18, Issue 2, 1999, Pages 122-123

  Laiho, K Kari ^a   Tiitinen, S ^a   Kaarela, K ^a   Helin, H ^b   Isomaki H ^a  

^a RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Amyloidosis; Ankylosing spondylitis; Juvenile chronic arthritis; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

AMYLOIDOSIS; ANKYLOSING SPONDYLITIS; ARTICLE; BIOPSY; DISEASE ASSOCIATION; FINLAND; HUMAN; INCIDENCE; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS;

AMYLOIDOSIS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; FINLAND; HUMANS; INCIDENCE; SPONDYLITIS, ANKYLOSING;

EID: 0032960338     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050068     Document Type: Article

References (14)

1. Tiitinen S, Kaarela K, Helin H, Kautiainen H, Isomäki H. Amyloidosis: incidence and early risk factors in patients with rheumatoid arthritis. Scand J Rheumatol 1993;22:158-61.
2. Tiitinen S, Myllykangas R, Helin H, Kaarela K. Modern trends in the diagnosis of secondary amyloidosis. Scand J Rheumatol 1988;17(suppl 67):30-1.
3. Puchtler H, Sweat F, Levine M. On binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-64.
4. Missen GAK, Taylor JD. Amyloidosis in rheumatoid arthritis. J Pathol Bact 1956;71:179-92.
5. Calkins EG, Cohen AS. Diagnosis of amyloidosis. Bull Rheum Dis 1960;10:215-8.
6. Wright JR, Calkins E. Clinico-pathologic differentiation of common amyloid syndromes. Medicine 1981;60:429-48.
7. Husby G. Amyloidosis and rheumatoid arthritis. Clin Exp Rheumatol 1985;3:173-80.
8. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Isomäki H. Shortening of life and causes of excess mortality in a population-based series of subjects with rheumatoid arthritis. Clin Exp Rheumatol 1995;13:149-53.
9. Savolainen A, Isomäki H. Decrease in the number of deaths from secondary amyloidosis in patients with juvenile rheumatoid arthritis. J Rheumatol 1993;20:1201-3.
10. Savolainen HA, Ylijoki HE. Declining prevalence of secondary amyloidosis in JCA. Clin Exp Rheumatol 1995;13:551.
11. Kremer JM, Lee JK. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 1986;29:822-31.
12. Boerbooms AM, Jeurissen ME, Westgeest AA, Theunissen H, Van de Putte LB. Methotrexate in refractory rheumatoid arthritis. Clin Rheumatol 1988;7:249-56.
13. Drosos AA, Psychos D, Andonopoulos AP, Stefaniki-Nikou S, Tsianos EB, Moutsopoulos HM. Methotrexate therapy in rheumatoid arthritis. A two year prospective follow-up. Clin Rheumatol 1990;9:333-41.
14. Klaukka T, Rajaniemi S. Reuman lääkekustannukset vaihtelevat alueittain suuresti. TABU 1997;5:30-1.